Which blood glucose monitors are FDA approved for pediatric use?

Updated: Apr 08, 2015
  • Author: Benjamin Daniel Liess, MD; Chief Editor: George T Griffing, MD  more...
  • Print


In February 2014, the FDA expanded its approval of the Dexcom G4 Platinum continuous glucose monitoring (CGM) system to include use in children aged 2 to 17 years of age, making it the first CGM system approved for use in young children. The FDA cautions that in studies in pediatric patients, the device was not as accurate as it is in adults, and its ability to issue an alert at glucose levels in the hypoglycemic range in children was poor. The product’s label will include warnings about these limitations. [1, 2]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!